Posted by Michael Wonder on 08 Aug 2023
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
8 August 2023 - Managed entry agreements continue to emerge in health technology assessment based decision-making, to address evidentiary uncertainties arising therein.
Evidence on the health technology assessment criteria criteria that influence the uptake of managed entry agreements (MEAs) remains scarce. This study explores the health technology assessment criteria that determine (i) if an health technology assessment funding decision will be listed with conditions other than a MEA, or with a MEA as a condition, and ii) the MEA type implemented (i.e., financial, outcomes based, or combination).
